155
Participants
Start Date
September 18, 2018
Primary Completion Date
May 1, 2020
Study Completion Date
May 1, 2020
SOV2012-F1
Oral preparation of testosterone undecanoate (TU). Strengths of 100 mg TU, 150 mg TU and 200 mg TU
Manhattan Medical Research Practice, PLLC, New York
Accumed Research Associates, Garden City
Urologic Consultant of SE Pennyslvania, Bala-Cynwyd
Rapha Institute for Clinical Research, Fayetteville
Coastal Carolina Research Center, Mt. Pleasant
Jacksonville Impotence Treatment Center, Jacksonville
Oviedo Medical Research, LLC, Oviedo
My Community Research Center, Miami
South Florida Medical Research, Aventura
PAB Clinical Research, Brandon
Meridien Research, St. Petersburg
Alabama Clinical Therapeutics, LLC, Birmingham
Coastal Clinic Research Inc, Mobile
University Diabetes Endocrine Consultants, Chattanooga
Quality Clinical Research, Inc., Omaha
Centex Studies, Inc., Lake Charles
Centex Studies, Inc., Houston
Northwest Clinical Trials, Boise
Palm Research Center, Inc., Las Vegas
Lead Sponsor
Collaborators (1)
Syneos Health
OTHER
Marius Pharmaceuticals
INDUSTRY